Wiktor AE - Search Results

1

TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.

Sukov WR, Hodge JC, Lohse CM, Leibovich BC, Thompson RH, Pearce KE, Wiktor AE, Cheville JC. Sukov WR, et al. Among authors: wiktor ae. Am J Surg Pathol. 2012 May;36(5):663-70. doi: 10.1097/PAS.0b013e31824dd972. Am J Surg Pathol. 2012. PMID: 22498819

2

Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.

Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Hodge JC, et al. Among authors: wiktor ae. Mod Pathol. 2014 Jan;27(1):113-27. doi: 10.1038/modpathol.2013.83. Epub 2013 Jul 5. Mod Pathol. 2014. PMID: 23828314 Free article.

3

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.

Perez EA, Jenkins RB, Dueck AC, Wiktor AE, Bedroske PP, Anderson SK, Ketterling RP, Sukov WR, Kanehira K, Chen B, Geiger XJ, Andorfer CA, McCullough AE, Davidson NE, Martino S, Sledge GW, Kaufman PA, Kutteh LA, Gralow JR, Harris LN, Ingle JN, Lingle WL, Reinholz MM. Perez EA, et al. Among authors: wiktor ae. J Clin Oncol. 2011 Feb 20;29(6):651-9. doi: 10.1200/JCO.2010.30.2125. Epub 2011 Jan 18. J Clin Oncol. 2011. PMID: 21245420 Free PMC article.

4

Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.

Yoon HH, Shi Q, Sukov WR, Wiktor AE, Khan M, Sattler CA, Grothey A, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Yoon HH, et al. Among authors: wiktor ae. Clin Cancer Res. 2012 Jan 15;18(2):546-54. doi: 10.1158/1078-0432.CCR-11-2272. Clin Cancer Res. 2012. PMID: 22252257 Free PMC article.

5

Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma.

Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA. Yoon HH, et al. Among authors: wiktor ae. J Clin Oncol. 2012 Nov 10;30(32):3932-8. doi: 10.1200/JCO.2012.43.1890. Epub 2012 Sep 17. J Clin Oncol. 2012. PMID: 22987085 Free PMC article.

6

Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer.

Mansfield AS, Sukov WR, Eckel-Passow JE, Sakai Y, Walsh FJ, Lonzo M, Wiktor AE, Dogan A, Jenkins RB. Mansfield AS, et al. Among authors: wiktor ae. Am J Clin Pathol. 2013 Feb;139(2):144-50. doi: 10.1309/AJCP13GJAOJAYJMW. Am J Clin Pathol. 2013. PMID: 23355198

7

Development of an NPM1/MLF1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia.

Aypar U, Knudson RA, Pearce KE, Wiktor AE, Ketterling RP. Aypar U, et al. Among authors: wiktor ae. J Mol Diagn. 2014 Sep;16(5):527-532. doi: 10.1016/j.jmoldx.2014.05.004. Epub 2014 Jul 12. J Mol Diagn. 2014. PMID: 25027285 Free article.

8

Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.

Jin Z, Holubek M, Sukov WR, Sattler CA, Wiktor AE, Jenkins RB, Wu TT, Yoon HH. Jin Z, et al. Among authors: wiktor ae. Am J Clin Oncol. 2019 Feb;42(2):190-195. doi: 10.1097/COC.0000000000000495. Am J Clin Oncol. 2019. PMID: 30516569 Free PMC article.

9

Application of thrombolytic drugs on clotted blood and bone marrow specimens to generate usable cells for cytogenetic analyses.

St Antoine A, Ketterling MN, Sukov WR, Lowman J, Knudson RA, Sinnwell JP, Wiktor AE, Ketterling RP. St Antoine A, et al. Among authors: wiktor ae. Arch Pathol Lab Med. 2011 Jul;135(7):915-9. doi: 10.5858/2010-0085-OAR1.1. Arch Pathol Lab Med. 2011. PMID: 21732783 Free article.

10

Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines.

Shah MV, Wiktor AE, Meyer RG, Tenner KS, Ballman KV, Green SJ, Sukov WR, Ketterling RP, Perez EA, Jenkins RB. Shah MV, et al. Among authors: wiktor ae. J Clin Oncol. 2016 Oct 10;34(29):3502-3510. doi: 10.1200/JCO.2015.61.8983. J Clin Oncol. 2016. PMID: 27458302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page